Patients with skin conditions are three times more likely to experience pruritus, highlighting a critical link between dermatologic health and quality of life.
A parallel-group study of 806 MI patients found that beta-blocker treatment had a negative effect on depressive symptoms at both 6-10 weeks (β = 0.48) and 12-14 months (β = 0.41) post-MI, with effects most pronounced in those with prior beta-blocker exposure.
A recent study uncovers why participants learn differently from failure compared to success, shedding light on emotional and cognitive barriers that hinder learning. Published in Motivation Science, the study's findings reveal compelling insights.